Pantatosakis E, Karandrea D, Liapis E, Kondi-Pafiti A, Liapis A
Clin Exp Obstet Gynecol. 2016;43(6):849-852.
To study the expression of hormonal receptors, collagen, elastin, proteoglycans, and VIP in the vaginal wall of women with stress urinary incontinence (SUI).
Fifty-eight specimens of the anterior vaginal wall (28 women with SUI) were processed by Ventana immunostaining method.
Both groups were compatible for age, BMI, and obstetric history. Positive ER-α and ER-β immunoreaction was observed in 46.4% and 3.6% of SUI (43.3% and 33.3% of controls) (p < 0.05), respectively, and PR immunoreaction in 39.3% of SUI (46.7% of controls). Collagen I and III immunoreaction was observed in 28,6% and 21.4% of SUI (30.% and 36.7% of controls), respectively, and elastin, decorin, and fibromodulin immunoreaction in 10.7%, 10.7%, and 10.7% of SUI (50%, 33.3%, 33,.3% of controls) (p < 0.05), respectively. VIP immunoreaction was observed in 7.1% of SUI (36.7% of controls).
Imunoexpression of ER-P, elastin, decorin, fibromodulin, and VIP was significantly lower in SUI than controls, showing that the ER-β dependent re-modeling of the extracellular matrix of vaginal tissues is the main mechanism of SUI.
研究压力性尿失禁(SUI)女性阴道壁中激素受体、胶原蛋白、弹性蛋白、蛋白聚糖和血管活性肠肽(VIP)的表达。
采用Ventana免疫染色法处理58例阴道前壁标本(28例SUI女性)。
两组在年龄、体重指数和产科病史方面具有可比性。SUI组中分别有46.4%和3.6%观察到雌激素受体α(ER-α)和雌激素受体β(ER-β)免疫反应阳性(对照组分别为43.3%和33.3%)(p<0.05),SUI组中39.3%观察到孕激素受体(PR)免疫反应阳性(对照组为46.7%)。SUI组中分别有28.6%和21.4%观察到I型和III型胶原蛋白免疫反应阳性(对照组分别为30%和36.7%),SUI组中分别有10.7%、10.7%和10.7%观察到弹性蛋白、核心蛋白聚糖和纤调蛋白免疫反应阳性(对照组分别为50%、33.3%、33.3%)(p<0.05)。SUI组中7.1%观察到VIP免疫反应阳性(对照组为36.7%)。
SUI患者中ER-β、弹性蛋白、核心蛋白聚糖、纤调蛋白和VIP的免疫表达明显低于对照组,表明阴道组织细胞外基质的ER-β依赖性重塑是SUI的主要机制。